Ticker > Company >

Cipla share price

Cipla Ltd.

NSE: CIPLA BSE: 500087 SECTOR: Pharmaceuticals & Drugs  522k   3k   598

1506.55
+4.45 (0.30%)
BSE: 13 Jun 04:01 PM

Price Summary

Today's High

₹ 1510

Today's Low

₹ 1480.9

52 Week High

₹ 1702

52 Week Low

₹ 1310.05

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

121685.22 Cr.

Enterprise Value

121352.02 Cr.

No. of Shares

80.77 Cr.

P/E

23.59

P/B

3.79

Face Value

₹ 2

Div. Yield

1.06 %

Book Value (TTM)

₹  397.41

CASH

333.2 Cr.

DEBT

0 Cr.

Promoter Holding

29.2 %

EPS (TTM)

₹  63.86

Sales Growth

15.54%

ROE

14.14 %

ROCE

18.88%

Profit Growth

73.23 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Cipla Ltd.

Paracip Montair LC Cipmolnu Dytor Moxicip Novamox Lametec Ibugesic Fourderm CPink CDense Productiv nicotex ActivKids immuno boosters cofsils CIPHANDS OMNIGEL CORYX BRONCOL COUGH SYRUP Cheston Asthalin Norflox Urimax CIPREMI Aerocort Budecort Duolin Foracort Seroflo Amlopres Atorlip Ciplar Cresar Clopivas Azee Imatib Kelfer Lamivir Tenvir Ibugesic Plus Omnigel Norflox-TZ Unobiotics Cipladine Clocip Maxirich Prolyte ORS MamaXpert Ciphands

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year15.54%
3 Year13.61%
5 Year6.02%

Profit Growth

1 Year62.22%
3 Year18.21%
5 Year16.64%

ROE%

1 Year14.14%
3 Year12.29%
5 Year12.37%

ROCE %

1 Year18.88%
3 Year16.59%
5 Year16.6%

Debt/Equity

0

Price to Cash Flow

32.65

Interest Cover Ratio

245.2948

CFO/PAT (5 Yr. Avg.)

1.14576472967456

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 29.20 0.00
Dec 2024 29.19 0.00
Sep 2024 30.92 0.00
Jun 2024 30.91 0.00
Mar 2024 33.47 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 22.01551196298% for the Past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 245.2948.
  • The Company has been maintaining an effective average operating margins of 23.1326212942778% in the last 5 years.
  • Company’s PEG ratio is 0.322359668231135.
  • The company has an efficient Cash Conversion Cycle of -29.628 days.
  • Company has a healthy liquidity position with current ratio of 5.191.
  • The company has a good cash flow management; CFO/PAT stands at 1.14576472967456.

 Limitations

  • The company has shown a poor revenue growth of 13.6102020134256% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 4036.66 4501.05 4775.03 4970.88 4797.89
Total Expenditure 3208.77 3141.19 3336.99 3309.05 3479.18
Operating Profit 827.89 1359.86 1438.04 1661.83 1318.71
Other Income 538.61 213.52 289.14 188.69 293.37
Interest 5.45 5.07 3 3.55 3.49
Depreciation 136.81 137.86 145.71 142.62 147.7
Exceptional Items 0 0 0 0 294.66
Profit Before Tax 1224.24 1430.45 1578.47 1704.35 1755.55
Tax 242.21 374.51 400.31 266.2 270.15
Profit After Tax 982.03 1055.94 1178.16 1438.15 1485.4
Adjusted EPS (Rs) 12.16 13.08 14.59 17.81 18.39

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 12659.15 11302.71 15380.82 14345.34 16574.34
Total Expenditure 9972.77 8235.3 11669.59 11000.23 12090.19
Operating Profit 2686.38 3067.41 3711.23 3345.11 4484.15
Other Income 913.76 230.28 666.7 464.57 1070.66
Interest 36.05 45.07 26.93 22.27 20.25
Depreciation 599.78 468.62 546.62 595.91 587.59
Exceptional Items 0 0 0 -185.9 0
Profit Before Tax 2964.31 2784 3804.38 3005.6 4946.97
Tax 646.14 739.35 921.8 861.54 1232.78
Net Profit 2318.17 2468.28 2957.93 2513.47 4077.25
Adjusted EPS (Rs.) 28.75 25.35 35.73 26.56 46

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 161.25 161.29 161.36 161.43 161.47
Total Reserves 17241.71 19766.27 22352.19 24476.66 27812.45
Borrowings 0 0 0 0 0
Other N/C liabilities 383.41 344.24 276.16 258.64 217.06
Current liabilities 2619.29 2691.94 2632.37 2699.74 2862.25
Total Liabilities 20405.66 22963.74 25449.05 27596.47 31053.23
Assets
Net Block 4024.54 3942.66 3846.57 3747.28 3603.14
Capital WIP 255.73 275.04 186.26 441.53 580.9
Intangible WIP 64 80.07 81.42 62.72 89.37
Investments 6355.32 7720.99 8934.88 9137.91 9410.17
Loans & Advances 516.63 596.1 555.68 748.77 1904.67
Other N/C Assets 164.72 158.13 509.2 87.13 607.14
Current Assets 9024.72 10190.75 11335.04 13371.13 14857.84
Total Assets 20405.66 22963.74 25449.05 27596.47 31053.23
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 2964.31 3350.66 3905.08 3685.17 5432.14
Adjustment -35.73 520.41 73.26 269.57 -342.91
Changes in Assets & Liabilities -245.46 541.19 -270.88 164.57 -138.3
Tax Paid -664.98 -951.95 -934.03 -1084.26 -1224.16
Operating Cash Flow 2018.14 3460.31 2773.43 3035.05 3726.77
Investing Cash Flow -1127.18 -3361.33 -2464.14 -2758.09 -2882.9
Financing Cash Flow -693.89 -65.8 -426.72 -424.77 -708.83
Net Cash Flow 197.07 33.18 -117.43 -147.81 135.04

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 33.47 30.91 30.92 29.19 29.20
kamil hamied 1.36 1.36 1.36 1.36 1.36
m k hamied - 3.45 3.46 3.45 3.46
sophie ahmed 5.71 5.70 5.71 5.70 5.71
yusuf khwaja hameid 18.68 18.67 18.68 18.67 18.68
rumana hamied 1.23 0.61 0.61 - -
samina hamied 2.22 1.11 1.11 - -
m k hamied 3.46 - - - -
okasa pharma private limi... 0.02 - - - -
shirin hamied 0.79 - - - -
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 66.53 69.09 69.08 70.81 70.80
axis mutual fund trustee ... - - - - 1.14
dsp healthcare fund - - - - 1.90
government pension fund g... 2.36 2.08 2.11 2.69 2.53
hdfc large and mid cap fu... - - - - 5.13
icici prudential bharat c... - - - - 1.70
investor education and pr... - 0.33 0.33 0.32 0.32
kotak mahindra trustee co... - - - - 1.03
lici new pension plus sec... - - - - 4.16
nps trust -a/c lic pensio... - - - - 1.15
parag parikh arbitrage fu... - - - - 1.02
sbi long term equity fund... - 3.24 - 2.85 2.79
uti conservative hybrid f... - - - - 1.06
vanguard total internatio... - - - - 1.00
aditya birla sun life tru... - - - 1.02 -
axis elss tax saver fund - - - 1.17 -
dsp multicap fund - - - 1.76 -
hdfc mutual fund - hdfc m... - - - 5.11 -
icici prudential nifty50 ... - - - 1.80 -
kotak mahindra trustee co... - - - 1.17 -
lic 3.67 3.53 - 3.41 -
nps - 1.58 - 1.45 -
uti elss tax saver fund - - - 1.07 -
hdfc mutual fund-hdfc arb... - - 5.11 - -
icici prudential equity a... - - 1.11 - -
kotak equity hybrid - - 1.03 - -
lici money plus balanced ... - - 3.13 - -
sbi arbitrage opportuniti... - - 2.75 - -
uti nifty 50 index fund - - 1.04 - -
hdfc mutual fund - hdfc f... - 4.94 - - -
icici prudential s&p bse ... - 1.12 - - -
uti nifty index fund - 1.01 - - -
hdfc mutual fund 4.47 - - - -
investor education and pr... 0.33 - - - -
nps trust 1.66 - - - -
sbi mutual fund 4.23 - - - -

Annual Reports

Title Action
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY ACTION
Credit CARE RATINGS
Credit CARE
Credit FITCH
TYPE AGENCY ACTION
Research BOB Capital Market
Research Report By:
Research BOB Capital Market
Research BOB Capital Market
Research BOB Capital Market
Research BOB Capital Market
Research BOB Capital Market
Research BOB Capital Market
Research BOB Capital Market
Research BOB Capital Market
Research BOB Capital Market
Research Edelweiss
Research BOB Capital Markets Ltd.
Research SMC online

Concalls & Presentations

TYPE QUARTER ACTION
Concall Q4FY24
Concall Q4FY21
Concall Q3FY24
Concall Q3FY22
Concall Q3FY22
Concall Q3FY21
Concall Q3 FY20
Concall Q2FY24
Concall Q2FY21
Concall Q2FY20
Concall Q1FY24
Concall Q1FY24
Concall Q1FY23
Concall Q1FY22
Concall Q1FY21
TYPE QUARTER ACTION
Presentation Q4FY25
Presentation Q4FY24
Presentation Q4FY21
Presentation Q3FY25
Presentation Q3FY24
Presentation Q3FY21
Presentation Q3 FY20
Presentation Q2FY24
Presentation Q2FY22
Presentation Q2FY21
Presentation Q1FY25
Presentation Q1FY24
Presentation Q1FY22
Presentation Q1FY21
Presentation Q1FY20

Company News

Cipla Stock Price Analysis and Quick Research Report. Is Cipla an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Cipla and its performance over the period of time. Cipla stock price today is Rs 1505.2.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Cipla cash from the operating activity was Rs 3726.77 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Cipla has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Cipla , the EPS growth was 73.1889 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Cipla has OPM of 27.0547726183969 % which is a good sign for profitability.
     
  • ROE: Cipla have a average ROE of 14.1415 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Cipla is Rs 1505.2. One can use valuation calculators of ticker to know if Cipla share price is undervalued or overvalued.
Last Updated on:
Brief about Cipla
X